Prognostic Value of Serum Lactate Dehydrogenase in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic Value of Serum Lactate Dehydrogenase in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
Authors
Keywords
Renal cell carcinoma, Meta-analysis, Prognosis, Cancer treatment, Glycolysis, Publication ethics, Surgical and invasive medical procedures, Biomarkers
Journal
PLoS One
Volume 11, Issue 11, Pages e0166482
Publisher
Public Library of Science (PLoS)
Online
2016-11-19
DOI
10.1371/journal.pone.0166482
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy
- (2016) Jian-Zhong Shou et al. CHINESE MEDICAL JOURNAL
- Prognostic Significance of Sarcopenia in Patients with Metastatic Renal Cell Carcinoma
- (2016) Hiroshi Fukushima et al. JOURNAL OF UROLOGY
- Body mass index and age are additional prognostic factors in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors
- (2016) Yan Song et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Clinical usefulness of PI3K/Akt/mTOR genotyping in companion with other clinical variables in metastatic renal cell carcinoma patients treated with everolimus in the second and subsequent lines
- (2015) L. Bodnar et al. ANNALS OF ONCOLOGY
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Lactate dehydrogenase 5: An old friend and a new hope in the war on cancer
- (2015) Katarzyna Augoff et al. CANCER LETTERS
- Efficacy of Targeted Treatment Beyond Third-Line Therapy in Metastatic Kidney Cancer: Retrospective Analysis From a Large-Volume Cancer Center
- (2015) Sonia Vallet et al. Clinical Genitourinary Cancer
- Trends in Metastatic Kidney Cancer Survival From the Cytokine to the Targeted Therapy Era
- (2015) Liam C. Macleod et al. UROLOGY
- Pretherapeutic Plasma Fibrinogen Level is an Independent Survival Predictor in Renal Cell Carcinoma
- (2015) Takeshi Sasaki et al. Oncology Research and Treatment
- Clinical Outcomes and Survival of Advanced Renal Cancer Patients in Phase I Clinical Trials
- (2014) Laeeq Malik et al. Clinical Genitourinary Cancer
- Lactate Dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma
- (2014) Hala Girgis et al. Molecular Cancer
- Prognostic factors in renal cell carcinoma patients treated with sorafenib: results from the Czech registry
- (2014) Katerina Kubackova et al. Targeted Oncology
- Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma
- (2013) R J Motzer et al. BRITISH JOURNAL OF CANCER
- Improvement of prognosis in patients with metastatic renal cell carcinoma and Memorial Sloan-Kettering Cancer Center intermediate risk features by modern strategy including molecular-targeted therapy in clinical practice
- (2013) Tomomi Kamba et al. International Journal of Clinical Oncology
- Association between hemoglobin, calcium, and lactate dehydrogenase variability and mortality among metastatic renal cell carcinoma
- (2013) Bulent Cetin et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Hand-Foot Skin Reaction is Associated with the Clinical Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Sorafenib
- (2013) K. Nakano et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Clinical Outcomes for Patients with Metastatic Renal Cell Carcinoma Treated with Alternative Sunitinib Schedules
- (2013) Bradley J. Atkinson et al. JOURNAL OF UROLOGY
- Predicting survival after targeted therapy for mRCC
- (2013) Melanie Clyne Nature Reviews Urology
- Clinical and laboratory prognostic factors in patients with metastatic renal cell carcinoma treated with sunitinib and sorafenib after progression on cytokines
- (2013) Alexandr Poprach et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Clinical prognostic factors associated with outcome in patients with renal cell cancer with prior tyrosine kinase inhibitors or immunotherapy treated with everolimus
- (2013) Robert J. Amato et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma
- (2012) Shi L. Sheng et al. FEBS Journal
- High preoperative plasma fibrinogen is an independent predictor of distant metastasis and poor prognosis in renal cell carcinoma
- (2012) Jun Du et al. International Journal of Clinical Oncology
- Long-term Survival Following Partial vs Radical Nephrectomy Among Older Patients With Early-Stage Kidney Cancer
- (2012) Edward C. Norton JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Serum Lactate Dehydrogenase Predicts for Overall Survival Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Inhibition of Mammalian Target of Rapamycin
- (2012) Andrew J. Armstrong et al. JOURNAL OF CLINICAL ONCOLOGY
- Better survival in patients with metastasised kidney cancer after nephrectomy: A population-based study in the Netherlands
- (2011) K.K.H. Aben et al. EUROPEAN JOURNAL OF CANCER
- Early Primary Tumor Size Reduction Is an Independent Predictor of Improved Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib
- (2011) E. Jason Abel et al. EUROPEAN UROLOGY
- Erythrocyte sedimentation rate kinetics as a marker of treatment response and predictor of prognosis in Chinese metastatic renal cell carcinoma patients treated with sorafenib
- (2011) Hai-Liang Zhang et al. INTERNATIONAL JOURNAL OF UROLOGY
- Is Memorial Sloan-Kettering Cancer Center risk classification appropriate for Japanese patients with metastatic renal cell carcinoma in the cytokine era?
- (2011) Nobuo Shinohara et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomy
- (2010) S. L. Richey et al. ANNALS OF ONCOLOGY
- Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma
- (2010) A N Jeppesen et al. BRITISH JOURNAL OF CANCER
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Lactate dehydrogenase as prognostic factor in limited and extensive disease stage small cell lung cancer – A retrospective single institution analysis
- (2010) Andreas Hermes et al. RESPIRATORY MEDICINE
- Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005)
- (2008) Arie S. Belldegrun et al. CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now